fbpx Skip to main content
 

Search

Janssen Search

Search results

762 SEARCH RESULTS FOR

research-development

Not finding what you're looking for? Visit Janssen in your country.
PAGE 10 OF 77

Pages

Our Trade Association Memberships At Janssen, we strive to discover and develop transformational medicines to help people around the world live longer, healthier and more productive lives.  Sound and well-considered public policies are critical to ensure ...

Martine Lewi, MBA, Ph.D. SCIENTIFIC DIRECTOR, JCI Tine Lewi is the Scientific Director for Janssen Clinical Innovation based in Belgium. Tine is responsible for leading patient data for research initiatives and introducing novel projects in the area of ...

RUXANDRA DRAGHIA-AKLI, M.D., Ph.D. GLOBAL HEAD JOHNSON & JOHNSON GLOBAL PUBLIC HEALTH R&D JANSSEN RESEARCH & DEVELOPMENT Ruxandra Draghia-Akli, M.D., Ph.D., is Global Head, Johnson & Johnson Global Public Health R&D. In this role, ...

The Mission That Binds Us   Those of us who work in drug development, we don’t all have the same journey to our profession. Some of us were brilliant at math and science, some desired to be challenged daily and others wanted to bring our creativity into ...

DAVID M. LEE, M.D., Ph.D. GLOBAL THERAPEUTIC AREA HEAD IMMUNOLOGY David M. Lee, M.D., Ph.D., is Global Immunology Therapeutic Area Head for the Janssen Pharmaceutical Companies of Johnson & Johnson where he leads a team focused on end-to-end pipeline ...

Peter M. DiBattiste, M.D. is responsible for co-leading the Cardiovascular & Metabolism (CVM) Therapeutic Area at Janssen Research & Development, setting the strategy and leading the team in discovery and development of novel therapeutics for ...

NEELY MOZAFFARIAN, M.D., PH.D. VICE PRESIDENT AUTOANTIBODY PATHWAY AREA LEADER IMMUNOLOGY Neely Mozaffarian, M.D., Ph.D., is Vice President, Autoantibody Pathway Area Leader for the Immunology Therapeutic Area at Janssen Research & Development, LLC. ...

JUSTIN SCHEER, Ph.D. VICE PRESIDENT GENE THERAPY AND GENE DELIVERY PLATFORMS Justin Scheer, Ph.D. is Vice President of Gene Therapy and Gene Delivery Platforms for Janssen BioTherapeutics (JBIO), the biotherapeutics engine of Janssen Research & ...

Gene Expression & Skin Clearing in Psoriasis   Understanding the intricacies of psoriasis and how therapies act on the disease can help to inform clinicians and their patients as they seek to make important treatment decisions. As I participate this ...

Teaming up to Defeat Multiple Myeloma A molecular view of the CAR-T therapy at work. The early data results seemed almost too good to be true. That's what Sen Zhuang, M.D., Ph.D., Vice President, Oncology Clinical Research, Janssen Research & ...

762 SEARCH RESULTS FOR

research-development

Not finding what you're looking for? Visit Janssen in your country.
PAGE 10 OF 77

Pages